References
- Petta S, Cammà C, Cabibi D, Di Marco V, Craxì A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;34(7): 757-66.
- Stine JG, Chalasani NP. Drug hepatotoxicity. Clin Liver Dis. 2017; 21(1):103-13.
- Timasheva GV, Bakirov AB, Mukhammadieva GF, Smolyankin DA, Khusnutdinova NY, Karimov DD. Evaluation of the effectiveness of the use of hepatoprotector in acute liver damage by various toxicants in the experiment. Hygiene and Sanitation. 2021;100(11):1292-7.
- Morellato AE, Umansky C, Pontel LB. The toxic side of one-carbon metabolism and epigenetics. Redox Biology.
- Rembold H, Gyure WL. Biochemistry of the pteridines. Angewandte Chemie International Edition in English. 1972;11(12):1061-72.
- Pfleiderer W. Pteridines. Second Supplements to the 2nd Edition of Rodd’s Chemistry of Carbon Compounds. 1991:269-330.
- Bi X, Li J, Li J, Shi W, Dai Y, Li Q, et al. Design, synthesis and biological evaluation of novel 4,5-dihydro-[1,2,4]triazolo[4,3-f] pteridine derivatives as potential BRD4 inhibitors. Bioorg Med Chem. 2019;27(13):2813-21.
- Ma F, Lü G, Zhou WF, Wang QJ, Zhang YH, Yao QZ. Synthesis and biological evaluation of 2,4-diaminopteridine derivatives as nitric oxide synthase inhibitor. Chin Chem Lett. 2009;20(4):420-2.
- Cavazzuti A, Paglietti G, Hunter WN, Gamarro F, Piras S, Loriga M, et al. Discovery of po-tent pteridine reductase inhibitors to guide antiparasite drug development. PNAS. 2008;105(5):1448-53.
- Corona P, Gibellini F, Cavalli A, Saxena P, Carta A, Loriga M, et al. Structure-based selec-tivity optimization of piperidine–pteridine derivatives as potent leishmania pteridine reductase inhibitors. J Med Chem. 2012;55(19):8318-29.
- Ghoneim AA, Ahmed Elkanzi NA, Bakr RB. Synthesis and studies molecular docking of some new thioxobenzo[g]pteridine derivatives and 1,4-dihydroquinoxaline derivatives with glycosidic moiety. JTUMED. 2018;12(6):774-82.
- Nosulenko IS, Kazunin MS, Kinichenko AO, Antypenko OM, Zhurakhivska LR, Vos-koboinik OY, et al. Dihydrofolate reductase inhibitors among pteridine and furo[3,2-g]pteridine derivatives. Biopolym Cell. 2021;37(2):143-52.
- Milstien S. Chemistry and biology of Pteridines and folates. Proceedings of the 12th International Symposium on pteridines and folates, National Institutes of Health, Bethesda, Maryland, June 17-22, 2001. Boston: Kluwer Academic Publishers; 2002.
- Abu-Hashem AA, El-Shazly M. Synthesis of new isoxazole-, pyridazine-, pyrimidopyrazines and their anti-inflammatory and analgesic activity. Med Chem. 2018;14(4):356-71.
- Kazunin M, Groma N., Nosulenko I., Kinichenko A., Antypenko O, Shvets V, Voskoboinik O., Kovalenko S. Тhio-containing pteridines: synthesis, modification and biological activity. Archiv der Pharmazie. 2022:e2200252.
- ProTox-II – Prediction of Toxicity of Chemicals. [https://tox-new.charite.de/protox_II/index.php?site=home.-do] (access: 11 May 2022)
- Kozhem'yakin YuM, Khromov OS, Filonenko MA. Scientific and practical recommendations for the development of laboratory creatures and robots. K.: Avitsena; 2002:156.
- Prozorovskiy VB, Prozorovskaya MP, Demchenko VM. Express method for determining the average effective dose and its errors. Farmakol Toxicol. 1978;4:497-502.
- European convention for the protection of vertebrate animals used for experimental and other scientific purposes. European Treaty Series. 1986; No. 123. Strasbourg: Council of Europe.
- Stefanov OV. Preclinical study of drugs (methodical recommendation). Kyiv: Avitsena; 2001.
- Morellato AE, Umansky C, Pontel LB. The toxic side of one-carbon metabolism and epigenetics. Redox Biology. 2021;40:101850.
- Mazur IA, Voloshin NA, Chekman IS. Thiotriazolin: pharmacological aspects and clinical application. Lvov: Zaporozhye; 2005;160.
- Gudyvok Ya, Kupnovitska IG, Golubeva MG Thiotriazolin: clinicopathogenetic aspects in liver lesions. Herald Pharmacol Pharm. 2005; 7:7-9.
- Bhakuni GS, Bedi O, Bariwal J, Deshmukh R, Kumar P. Animal models of hepatotoxicity. Inflammation Res. 2015;65(1):13-24.
- Menshikov VV, Delektorskaya LN, Zolotnitskaya RP. Laboratory research methods in the clinic. Moskow: Medicine, 1987:386.
- Bergmeyer HU, Horder M and Rej R: International Federation of Clinical Chemistry (IFCC) Scientific Committee. Analytical section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 3: IFCC Method for Alanine Aminotransferase (EC 2.6.1.2). J Clin Chem Clin Biochem. 1986;24:481-95.
- Вergmeyer HU, Horder M, Rej R. International Federation of Clinical Chemistry (IFCC) Scientific Committee. Analytical section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC methods for the measurement of catalytic for aspirate aminotransferase (Lasparatate: 2- oxoglutarate aminotransferase, EC 2.6.1.1). J Clin Chem Clin Biochem. 1986;24:497-5103.
- Gutmann I, Bergmeyer H.U. Methods of enzymatic Analysis. New York: Academic Press;1974:1794-8.
- Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the Biuret reaction. J Biol Chem. 1949;177(2): 751-66.
- Bertis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemestry and Molecular Diagnostics. 4th ed. WB Saunders Co; 2005.
- Muller G., Fruhant A., Mathias B. Thiobarbiturasure-positive substanzen als indikatoren der lipid peroxidation. Gzamte Um Med Grenzgeb. 1986;41(24);673-6.
- Korolyuk MA, Ivanova, AI, Mayorova IG, Tokarev VE. Metod opredeleniya aktivnosti kata-lazy. Lab Delo Laboratory Case. 1988;1, 16-19.
- Best F. Uber Karminfarbung des Glykogens und der Kerne. Z Wiss. Mikr. 1906;23:319.
- Stefanov OV. Preclinical study of drugs (methodical recommendation). Kyiv: Avitsena; 2001.
- Yousefi‐Manesh H, Shirooie S, Partoazar A, Nikoui V, Estakhri MR, Bakhtiarian A. Hepato-protective effects of phosphatidylserine liposomes on carbon tetrachloride‐induced hepatotox-icity in rats. J Cell Biochem. 2019;120(7):11853-8.
- Aslanian MA, Bobrytska LA, Bereznyakova NL, Shpychak OS, Hrytsenko VI, Germanyuk TA, et al. Biochemical research of hepatoprotective activity of Lavaflam tablets in rats with subchronic hepatitis. Curr Issues Pharm Med Sci. 2020;33(1):10-3.
- D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol. 2006;44(1):217-31.
- Toxicological profile for carbon tetrachloride – agency for toxic. [https://www.atsdr.cdc.gov/toxprofiles/tp30.pdf] (access: 4 November 2022)
- Abouzied MM, Mahmoud SM, Wahid A, Ahmed AE, Okasha AM, Soliman HA, et al. A study of the hepatoprotective effect of plantago psyllium L. Seed extract against carbon tetra-chloride induced hepatic injury in rats. J Appl Biomed. 2020;18(2-3):80-6.
- Abramov SS. Lipid peroxidation and endogenous intoxication in animals, ways of correction: monograph. Vitebsk: UO VGAVM; 2007:208.
- Lee C-H, Park S-W, Kim YS, Kang SS, Kim JA, Lee SH, et al. Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. Biol Pharm Bull. 2007;30(10): 1898-904.